id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1070551,5bea6311-62c7-44a2-a4a6-24de371b8325,Q1,"STRATEGIC APPLICATIONS INTERNATIONAL, LLC",295337,LUKE COMMISSION,2011,first_quarter,MED,Secure funding for current and new programs.,"Health & Human Services, Dept of (HHS),U.S. Agency for International Development (USAID)",,,0,0,2011-01-27T12:48:22.740000-05:00
1070777,53ec246b-cab8-4783-a4f2-9e3cb461c684,Q1,MICHAEL SAULS,43638,MIT HOLDING INC,2011,first_quarter,MED,Educating Congress and the regulatory agencies about client's products; seeking EPA registration.,"Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-03-30T15:17:17.370000-04:00
1070782,d49b9607-84e9-4bc2-ba5e-9aa814d6fd07,Q1,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2011,first_quarter,MED,all issues related to pharmaceutical labeling,,25000,,0,0,2011-03-30T15:27:21.263000-04:00
1070833,8a4fa854-3472-4070-b678-8d9e60152d34,Q1,HOLLAND & KNIGHT LLP,18466,AABB,2011,first_quarter,MED,Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS.,"Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-03-31T12:01:17.820000-04:00
1070843,2a5467c0-682e-42ca-934c-76830b9821f9,Q1,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2011,first_quarter,MED,Hematology  and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2011-03-31T12:10:22.433000-04:00
1070851,c6b1bb39-0052-4adf-937a-7634680fc959,Q1,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2011,first_quarter,MED,Biomedical Research; CDC Hemophilia program; HRSA Hemophilia Program,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",40000,,0,0,2011-03-31T12:14:25.840000-04:00
1071028,4e514a4f-7499-4cce-9318-dd8aef615136,Q1,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2011,first_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2011-04-03T22:24:54.053000-04:00
1071040,9595cc09-066b-473a-bf6c-1035c5c5250d,Q1,MARSHALL BRACHMAN,6848,ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC,2011,first_quarter,MED,oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging in HR 3200 and equivalent Senate legislation; support HR 4173 to reverse cuts in 2010 PFS rule,"HOUSE OF REPRESENTATIVES,SENATE",9000,,0,0,2011-04-03T22:36:57.297000-04:00
1071043,d34b8b90-7d76-4c84-a14f-6aae378a6a9b,Q1,MARSHALL BRACHMAN,6848,CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE,2011,first_quarter,MED,"support HR 1293/S. 1338 equivalent in 111th Congress
reverse cardiac catheterization practice expense cuts","HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2011-04-03T22:39:58.263000-04:00
1071201,b3019e8b-6aba-4a6f-8f43-290e1e1405e8,Q1,BOB MOSS ASSOCIATES,51877,BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH),2011,first_quarter,MED,Securing continued support for Sanford Burnham's medical research from Congress.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2011-04-04T17:07:10.533000-04:00
1071476,97cbd3a8-89c0-4126-b6a7-852aa956f1d5,Q1,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2011,first_quarter,MED,"NIH Budget including Title VII & VIII programs
VA-Outpatient Clinic in N.C.(RFP-land acquisition)
Great Ape Protection Act (H.R.1326)","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)",,160000,0,0,2011-04-06T11:13:33.243000-04:00
1071565,68e8c93f-5eed-443a-8a64-2c1994d86d3e,Q1,HOLLAND & KNIGHT LLP,18466,"SHIRE PHARMACEUTICALS, INC",2011,first_quarter,MED,"Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products.  Participate in FDA stakeholder meetings re Prescription Drug User Fee program.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-04-06T12:42:13.967000-04:00
1071578,1f577934-986d-4181-8f9f-9bec69e207df,Q1,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,first_quarter,MED,Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-04-06T12:52:20.593000-04:00
1071680,9e2450c9-3ed9-4a74-93a0-f2f3fe0e47ea,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2011,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,59600,0,0,2011-04-06T15:37:20.920000-04:00
1071886,364dbe15-ab00-4856-8085-3b2a8ea21547,Q1,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2011,first_quarter,MED,Regarding funding for FY 11 pertaining to software communication system for chronic disease management,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2011-04-07T13:55:12.900000-04:00
1072019,210d98a6-503c-41e1-9f05-6bfc6e3963c1,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,COOLEY'S ANEMIA FOUNDATION,2011,first_quarter,MED,Drug review and approval process,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-07T16:50:50.947000-04:00
1072078,f4523e4b-c19d-477b-aa53-968b53875c09,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2011,first_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients.  Support additional funding for the ADAP program. 

Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-08T10:53:25.470000-04:00
1072177,e1171f7b-dfb0-4170-ba1e-925458678309,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2011,first_quarter,MED,Appropriations and Authorization legislation for FY 2012 in health care,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2011-04-08T12:18:12.173000-04:00
1072275,e0ba5a4a-6f6f-4f53-a815-187a74d0195b,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2011,first_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2011-04-08T15:07:05.423000-04:00
1072280,db0fd326-6593-449e-9d26-a08ad77d30c6,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2011,first_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",46000,,0,0,2011-04-08T15:09:08.800000-04:00
1072326,1d5e90af-22f6-4352-8142-09cbad6a0fa9,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2011,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-04-08T15:22:26.917000-04:00
1072370,ea00aa64-6bd2-400b-bbc9-3978c2947303,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2011,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2011-04-08T15:42:43.937000-04:00
1072517,e429a30a-7a4d-40c8-9edf-740b509b9b7f,Q1,"THE PETRIZZO GROUP, INC.",305932,"FATE THERAPEUTICS, INC.",2011,first_quarter,MED,"Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.","Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-10T11:14:15.143000-04:00
1072524,4c392508-9ae4-4a80-a19d-b89b0a41ca87,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE BIOMEDICAL RESEARCH INSTITUTE,2011,first_quarter,MED,Advocate for funding to support next - generation drug development for Leishmaniasis.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-10T11:24:17.257000-04:00
1073010,ed66ca43-7617-4cdf-bc38-11259b6ed0b0,Q1,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2011,first_quarter,MED,NONE,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE",,120000,0,0,2011-04-11T16:18:02.857000-04:00
1073073,ad6c9940-589e-4b04-bf56-340f4b6859e3,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2011,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-04-11T17:00:42.850000-04:00
1073089,4e1ae626-592c-4b9b-a1c8-114ed5a5372d,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2011,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11508,,0,0,2011-04-11T17:13:52.467000-04:00
1073103,b5c58240-d691-49bb-aced-f39da99456b5,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2011,first_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2011-04-11T17:24:59.107000-04:00
1073386,6feb4af9-dc89-40ee-b143-28a1008decbc,Q1,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2011,first_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-12T11:09:19.413000-04:00
1073856,759eb987-72e1-4516-a474-c47454b8be0d,Q1,"BALCH & BINGHAM, LLP",5197,BIOCRYST PHARMACEUTICALS INC,2011,first_quarter,MED,Federal response to the pandemic influenza outbreak and pandemic preparedness.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-12T15:41:47.133000-04:00
1073984,538f145d-1002-4f22-b23d-2f17852d9a84,Q1,POLICY DIRECTIONS INC.,31747,"VITAPATH GENETICS, INC.",2011,first_quarter,MED,"New regulatory requirements for diagnostics.
Seeking federal funding for novel genetic diagnostic tests.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-12T16:54:56.560000-04:00
1074040,a2ce4c1a-e752-4765-a7f2-854b65123821,Q1,JAMES P. KEESE,74556,INSTANTLABS MEDICAL DEVICE CORPORATION,2011,first_quarter,MED,"Issues pertaining to the Clinical Laboratory Imporvement Act (42 U.S.C. 263a) S. 510, H R 2751 - The FDA Food Safety Modernization Act, all provisions.","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2011-04-12T17:57:31.333000-04:00
1074169,53efca80-0f17-493a-a9d6-50da2c8f1e06,1T,CLARK & WEINSTOCK,9443,AUSTEN BIOINNOVATION INSTITUTE,2011,first_quarter,MED,Funding for medical research; health policy.,"Army, Dept of (Other),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Science & Technology Policy (OSTP),SENATE",,,0,1,2011-04-13T09:44:45.483000-04:00
1074256,6fe9eae3-081f-41bf-8b89-e2a8fe8bc515,Q1,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2011,first_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2011-04-13T10:53:30.017000-04:00
1074415,6d85cdc2-b80f-400d-bd63-1dc5474b698f,Q1,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2011,first_quarter,MED,Stem Cell Research Policy,"Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,120000,0,0,2011-04-13T12:26:09.273000-04:00
1074661,33303486-2641-4a53-a1b2-5a4b3f645093,Q1,THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK,38585,TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK,2011,first_quarter,MED,"NIH, GME, Title VII","HOUSE OF REPRESENTATIVES,SENATE",,11047,0,0,2011-04-13T14:38:32.723000-04:00
1074693,bbf22eea-21a5-48ec-b6e4-72c8cd2bb515,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2011,first_quarter,MED,"No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis
HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2011-04-13T14:49:50.183000-04:00
1074948,e444e0cc-e0d1-4974-9672-b250e0ac100a,Q1,LATHAM & WATKINS LLP,22201,BOSTON SCIENTIFIC CORPORATION,2011,first_quarter,MED,Congressional oversight of the Food and Drug Administration.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-13T16:57:13.143000-04:00
1074972,7b38c1e2-0dbd-4102-a74c-f89748d0f299,Q1,"AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES",1524,"AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO",2011,first_quarter,MED,"S. 3686, appropriations for the National Heart, Lung and Blood Institute included in the FY 2011 Labor, HHS and Education Appropriations bill",HOUSE OF REPRESENTATIVES,,23000,0,0,2011-04-13T17:15:35.357000-04:00
1075108,54b8855b-ad5e-4617-bf5e-9fc473ec6de3,Q1,BEN BARNES GROUP LP,5415,HUNTSMAN CANCER INSTITUTE,2011,first_quarter,MED,Medical research,"HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2011-04-13T18:26:46.750000-04:00
1075511,3742efae-1c2c-4863-bdb4-a9a3cf36a934,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,ISIS PHARMACEUTICALS,2011,first_quarter,MED,"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2011-04-14T11:17:24.677000-04:00
1075543,5f9dc4b3-e78c-4295-aadf-44fa2d451f3e,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,MAYO CLINIC,2011,first_quarter,MED,"Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility; more than 30,000 doctors and staff use this facility each day.  The multi-year Surface Transportation Authorization Act and the House THUD Subcommittee 2011 Transportation, Housing and Urban Development Appropriations Bill.","HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)",25000,,0,0,2011-04-14T11:25:39.437000-04:00
1075858,d18953cc-b8b8-461e-aaea-93e06a4afd8a,Q1,GOLDBUG STRATEGIES LLC,400701094,GENOMIC HEALTH INC.,2011,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Tricare payment of laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",110000,,0,0,2011-04-14T13:45:19.037000-04:00
1075868,7c708282-69c1-41e5-9543-fd37f108f305,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION,2011,first_quarter,MED,"No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
Continuing Resolutions, FY 2011
No Bill#, HHT Research and Treatment Act","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-14T13:49:24.440000-04:00
1075877,a318d775-8802-492f-8959-5f3b2bb26f5d,Q1,GOLDBUG STRATEGIES LLC,400701094,GENOMIC HEALTH INC.,2011,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.
Tricare payment of laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",110000,,0,0,2011-04-14T13:51:29.940000-04:00
1075901,9ea241b2-d7c3-4d60-a61a-1ba1de3d3ed6,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2011,first_quarter,MED,"No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research
No Bill#, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease
Bone Marrow Failure Disease Research and Treatment Act
Continuing Resolutions, FY 2011","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2011-04-14T13:56:38.737000-04:00
1075930,8ccd18fd-fba2-4425-9dbd-0e844f716acf,Q1,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2011,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-04-14T14:06:52.323000-04:00
1075984,5ffe2a9f-e61a-40fa-a472-91d241e44df8,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"SAGE PUBLICATIONS, INC.",2011,first_quarter,MED,"No Bill#, Federal Research Public Access Act
National Institutes of Health Open Access policy
No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-14T14:26:23.737000-04:00
1076054,c7982d88-3a07-4a19-81bb-c06c36f6846b,Q1,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2011,first_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-14T14:54:59.617000-04:00
1076157,b5261586-9b04-4b13-83cf-f13a687dbfb8,Q1,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2011,first_quarter,MED,"Appropriations for Federal Health Agencies
Elimination of Physician Signature Requirement Under Medicare PFS
Stark Self Referral Reform
Laboratory Workforce Shortage; Regulation of Laboratory Developed Tests","Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE",,50000,0,0,2011-04-14T15:24:01.670000-04:00
1076264,356f0db4-eb97-4a83-8306-360e872fcdf7,Q1,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2011,first_quarter,MED,"Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry.","HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2011-04-14T16:02:08.843000-04:00
1076338,d42355bc-eb3f-472c-a3a3-62dba2c66439,Q1,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,400382759,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2011,first_quarter,MED,"Urging members of Congress to introduce and co-sponsor H.R. 1513 and S. 810, the Great Ape Protection and Cost Savings Act, which would phase out invasive research on chimpanzees and retire chimpanzees owned by the federal government to permanent sanctuaries. Urging members of Congress to introduce and support legislation to encourage the government to promote medical simulation technologies.","HOUSE OF REPRESENTATIVES,SENATE",,11805,0,0,2011-04-14T16:45:54.700000-04:00
1076354,ec4007f0-1186-4989-8fe0-74039b017a92,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREECLAMPSIA FOUNDATION,2011,first_quarter,MED,Preeclampsia Research,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH)",10000,,0,0,2011-04-14T16:54:05.493000-04:00
1076366,f051891f-8c2b-40a9-bca2-4b621b01cc7e,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2011,first_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",40000,,0,0,2011-04-14T17:01:14.067000-04:00
1076401,c6f4d0fb-a2f0-4b3b-85ba-a287226fe592,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREVENT BLINDNESS,2011,first_quarter,MED,Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss.,"Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2011-04-14T17:18:34.593000-04:00
1076424,acfabf04-836d-4160-9788-a6f53896cd1b,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PATH,2011,first_quarter,MED,Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-14T17:29:47.633000-04:00
1076463,400dd994-3c56-4316-9a32-86a4131d3f94,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,RIVERAIN MEDICAL,2011,first_quarter,MED,Increasing awareness of lung cancer and making it a public health priority,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-14T17:41:03.583000-04:00
1076479,8fee103e-46ba-4421-8028-d0289a26a14f,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2011,first_quarter,MED,Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-14T17:45:12.143000-04:00
1076486,9b429ee2-02ac-4c3c-ba2c-0ebfbe9a05e1,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,OVARIAN CANCER NATIONAL ALLIANCE,2011,first_quarter,MED,Ovarian Cancer Research and Awareness; Implementation of Johanna's Law.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-14T17:48:15.907000-04:00
1076498,779f02c3-e2be-4490-abe8-4893725aa88a,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2011,first_quarter,MED,Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; S. 641 - Water for the World Act of 2009; H.R. 528 - Neglected Infections of Impoverished Americans Act; CDC Infection and Vector Borne Disease Programs.,"Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",30000,,0,0,2011-04-14T17:53:22.087000-04:00
1076509,3ca72f85-a858-4abb-b3dc-0853caedde83,Q1,"THREE BRIDGES ADVISORS, INC.",400689049,VAN SCOYOC ASSOCIATES (MT. DESERT ISLAND BIOLOGICAL LABORATORY (MDIBL)),2011,first_quarter,MED,Biomedical research funding for regenerative medicine program.,"HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2011-04-14T17:58:28.040000-04:00
1076738,9a9d9def-b2ed-4952-8fe3-473abbac0430,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,"BRIGHTON BIOTECH, INC.",2011,first_quarter,MED,"Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",10000,,0,0,2011-04-15T10:21:37.853000-04:00
1076774,71b10400-869b-4876-adb1-9d83a204c2df,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,COALITION FOR 21ST CENTURY MEDICINE,2011,first_quarter,MED,Issues concerning regulation of laboratory tests.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2011-04-15T10:34:58.863000-04:00
1076789,1bce3360-ec0b-4d67-be30-eb15307652a5,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2011,first_quarter,MED,"FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2011-04-15T10:41:06.173000-04:00
1076907,8b172da9-025e-4f87-9d31-11c639dc34eb,Q1,LIFE TECHNOLOGIES CORPORATION,400391833,LIFE TECHNOLOGIES CORPORATION,2011,first_quarter,MED,BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests.,"HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2011-04-15T11:30:18.263000-04:00
1077004,013ac45b-d118-47eb-bf49-fc8ea4b943e9,Q1,MAYO CLINIC,400270238,MAYO CLINIC,2011,first_quarter,MED,"Lab payment issues
Research funding","HOUSE OF REPRESENTATIVES,SENATE",,210000,0,0,2011-04-15T12:13:24.613000-04:00
1077020,57a1efb3-6eb4-40e3-864e-b16b41bb0b72,Q1,WEBMD HEALTH CORP.,55473,WEBMD HEALTH CORP,2011,first_quarter,MED,"Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and
consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records.",SENATE,,30000,0,0,2011-04-15T12:20:38.193000-04:00
1077335,0d3eccca-dcab-44b3-97e5-5bc9dc3d8350,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2011,first_quarter,MED,"Pending reintroduction of the  Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act; Psoriasis Data Collection.","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",60000,,0,0,2011-04-15T14:24:50.203000-04:00
1077344,738fa514-c5ae-4bb0-984a-049b2c789679,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2011,first_quarter,MED,"Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for 
rare diseases.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-15T14:28:54.157000-04:00
1077399,68bec15f-6f40-423b-8f0b-2e9c4a8256a2,Q1,"HEALTHFUTURES, LLC",400359646,ASSOCIATION FOR MOLECULAR PATHOLOGY,2011,first_quarter,MED,"Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics
No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act
No Bill#, BETTER Patient Care Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE",30000,,0,0,2011-04-15T14:43:22.837000-04:00
1078334,19d97675-1162-4961-9e89-023500c0217d,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,MOBILE MEDICAL INTERNATIONAL CORPORATION,2011,first_quarter,MED,"Develop partnership with Veterans Administration (VA) to provide mobile surgery units (MSUs) throughout system when VA operating rooms are under construction or renovation, or additional capacity is needed soon, thus saving the VA money and other benefits.","SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2011-04-15T22:12:37.790000-04:00
1078421,b81fd35b-65d4-4ebd-883c-8ed6bf59b60d,Q1,"CAPITOL CONSULTING GROUP, LLC",400366700,LIFECELL CORPORATION,2011,first_quarter,MED,"FY11 and 12 defense appropriations bill, Army medical research and development programs","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-16T11:52:36.997000-04:00
1078463,9620541d-b28a-4336-a701-adf54ae8c66c,Q1,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2011,first_quarter,MED,Medical research,SENATE,20100,,0,0,2011-04-16T15:20:02.190000-04:00
1078494,ba1c1a3e-d9fc-49a9-917f-dbb6aed3dab7,Q1,DUKE UNIVERSITY,314294,DUKE UNIVERSITY,2011,first_quarter,MED,"Medical, Disease Research, and Clinical Lab Issues","Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS)",,98001,0,0,2011-04-17T12:06:41.840000-04:00
1078585,307b1d74-ecc0-44c9-8952-91e9160b1dc8,Q1,PERSONALIZED MEDICINE COALITION,40046362,PERSONALIZED MEDICINE COALITION,2011,first_quarter,MED,"CER, CMS, Coverage of Genetic Testing","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,6416,0,0,2011-04-17T17:51:39.517000-04:00
1078635,f5fe53fc-936d-4d5d-a061-f1298b540e28,Q1,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2011,first_quarter,MED,"Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011 federal funding.
Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-17T21:36:13.060000-04:00
1078644,d53c11f9-4b19-417b-a9ba-5dfbd5fb75e8,Q1,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF MEDRAD INC.,2011,first_quarter,MED,Cell therapy delivery research,"Natl Aeronautics & Space Administration (NASA),Natl Institutes of Health (NIH)",,,0,0,2011-04-17T22:03:18.513000-04:00
1078770,dd1a8f62-241c-4b38-a70b-8a2474e89bed,Q1,SQUIRE PATTON BOGGS,30906,"MELA SCIENCES, INC.",2011,first_quarter,MED,FDA regulatory procedures with respect to melanoma detection systems.,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2011-04-18T08:12:38.147000-04:00
1078787,99c66a40-b2d1-4215-a7ec-cc0f98fbd274,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CANCER CARE ALLIANCE,2011,first_quarter,MED,"Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers.  Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Support introduction and passage of The Cancer Center Assistance for Renovation and Expansion Act, H.R. 5861.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-18T08:19:50.240000-04:00
1078816,17a67c88-6fbe-49bf-ba5b-16acd9cb8648,Q1,NELSON MULLINS RILEY & SCARBOROUGH,285871,SOCIETY OF BEHAVIORAL MEDICINE,2011,first_quarter,MED,NIH budget; health care prevention and wellness programs,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-18T08:29:10.707000-04:00
1078829,fb4c8820-9048-4914-9925-bc7436bb31a1,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2011,first_quarter,MED,"Advocate for federal funding for GAPPS Project -- Understanding Increased Risk of Preterm Birth and Stillbirth in a Post-Combat Setting.  This request is aimed at improving our understanding of factors which contribute to preterm and stillbirths around the world.  Specifically, federal funding would examine how and whether poor nutrition, impoverishment, the high stress of living in war-torn areas, and exposure to various toxins and pathogens increase rates of preterm birth and stillbirth rates.  This project will provide the U.S. Army with research that will inspire new diagnostics, therapeutics and other innovations to improve birth outcomes and prevent prematurity and stillbirths. This research will extrapolate to a broader range of maternal health conditions as they relate to the priorities of the Department of Defense for warfighter health.

Advocated for legislativion to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-18T08:43:17.513000-04:00
1078944,4539925a-8688-4f84-a7fc-3d9c4cacfd87,Q1,POLICY DIRECTIONS INC.,31747,ADVANCED LIFE SCIENCES,2011,first_quarter,MED,FDA regulatory pathway for new antibiotic medicines.,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-18T09:41:21.843000-04:00
1078982,bfc5fe10-2586-4481-a1f5-8f0e2a32ba3c,Q1,"HEALTHFUTURES, LLC",400359646,"NAVIGENICS, INC.",2011,first_quarter,MED,"Oversight and regulation of genetic testing
Direct to consumer genetic testing","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-18T09:45:36.343000-04:00
1079030,e9310c28-9d9d-41c1-bba0-023b97adb04d,Q1,"HEALTHFUTURES, LLC",400359646,LIFE TECHNOLOGIES,2011,first_quarter,MED,"No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory-developed tests No Bill#, BETTER Patient Care Act
Whole genome sequencing","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2011-04-18T09:56:03.483000-04:00
1079061,1866872b-575a-4491-ae80-556ee2f2a1a2,Q1,"THE PETRIZZO GROUP, INC.",305932,"SAGE THERAPEUTICS, INC.",2011,first_quarter,MED,"Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury  (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-18T10:01:20.237000-04:00
1079180,85a6ffdd-49f4-4df6-a683-2b4a59a327b6,Q1,"KSCW, INC.",21596,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS,2011,first_quarter,MED,Legislation and regulation affecting the Medical device industry,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-18T10:18:28.520000-04:00
1079289,e831f94c-484a-4d93-ad7a-3e31698bf9ac,Q1,"KSCW, INC.",21596,"MCBRIDE MEDICAL GROUP, INC.",2011,first_quarter,MED,"Physician Reimbursement, Innovative Delivery Systems","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2011-04-18T10:31:22.543000-04:00
1079394,5d9ae768-f676-4df2-a1ac-8a3907cfe9ac,Q1,"ALPINE GROUP PARTNERS, LLC.",1171,AMERICAN COLLEGE OF RADIOLOGY,2011,first_quarter,MED,reauthorization of Mamography Quality Standards Act (MQSA),"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2011-04-18T10:47:17.937000-04:00
1079424,e68fd23e-bb62-4c54-ac00-41c3c983f651,Q1,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2011,first_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-18T10:53:41-04:00
1079468,377f6032-55c0-45c3-92e2-9e88f3f02bbf,Q1,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2011,first_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research","Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2011-04-18T10:58:57.503000-04:00
1080986,4599b31d-b338-4124-9ea2-353d29145ac5,Q1,DENNY MILLER ASSOCIATES,25328,ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER,2011,first_quarter,MED,"Implementation of Patient Protection and Affordable Care Act (Public Law III - 148), provisions relating to the Center for Medicare and Medicaid Innovation grant program.  Federal funding/grant opportunities in the Dept of Health and Human Services.  Implementation of the Department of Defense Appropriations Act, 2010 (Public Law 111-118), Title IV, provisions relating to US Army medical research.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-18T14:49:56.170000-04:00
1081102,c6ab2e35-1072-4af9-b35b-6516b3ffaa47,Q1,DENNY MILLER ASSOCIATES,25328,SABEY CORPORATION,2011,first_quarter,MED,"Oversight and implementation of the Patient Protection and Affordable Care Act (Public Law 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2011-04-18T15:03:03.310000-04:00
1081256,b4f187a4-6e09-4678-8ef4-6f00c24d6f59,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2011,first_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,84657,0,0,2011-04-18T15:17:20.403000-04:00
1081941,7a581052-325b-48b2-87d6-0dfe6930f376,Q1,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2011,first_quarter,MED,"The Centers for Medicare and Medicaid Services (CMS) required in the 2011 Medicare Physician Fee Schedule Final Rule that laboratory requisition forms be signed by the ordering physician.  We asked that CMS consider delaying enforcement of the requirement, possibly for an additional nine months.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",,130000,0,0,2011-04-18T17:00:40.887000-04:00
1082194,6f17878b-3030-44f1-a917-315f71511c26,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,"VIVUS, INC.",2011,first_quarter,MED,FDA approval process,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2011-04-18T17:35:49.417000-04:00
1082532,b60a8552-56e3-4b86-9d9a-000ac469ae0f,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,ZOLL DATA SYSTEMS,2011,first_quarter,MED,Issues relating to healthcare IT funding,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2011-04-18T19:40:30.367000-04:00
1082617,c920bfd3-a6c1-43af-ab39-57ef17c0068e,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,ABBOTT LABORATORIES,2011,first_quarter,MED,"Healthcare reform
Legal reform
Theft of medical products",,20000,,0,0,2011-04-18T21:06:10.910000-04:00
1082795,2bc0e67f-55bc-4f56-aa53-00818a25a694,Q1,VAN SCOYOC ASSOCIATES,39837,MEDICINES FOR MALARIA VENTURE,2011,first_quarter,MED,USAID and Malaria research and development issues and initiatives,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)",30000,,0,0,2011-04-19T06:18:35.340000-04:00
1082804,40489966-4c3c-442a-a7ee-a93981623291,Q1,VAN SCOYOC ASSOCIATES,39837,CUREMARK LLC,2011,first_quarter,MED,Therapeutic treatment for autism issues generally.,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2011-04-19T06:23:38.807000-04:00
1083426,87447146-af02-4b0c-ba38-f4b25b567de3,Q1,AMERICAN SOCIETY OF HEMATOLOGY,59171,AMERICAN SOCIETY OF HEMATOLOGY,2011,first_quarter,MED,"H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act
General Hematology Public Health and Research Issues
Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues
Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease
Thrombosis
Electronic Health Records (EHR)
Hematology/Oncology treatment Issues
Comparative Effectiveness Research
S. 296, the Preserving Access to Life-Saving Medications Act","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Nuclear Regulatory Commission (NRC),SENATE",,30000,0,0,2011-04-19T09:26:33.130000-04:00